Background. Whipple disease (WD) is a chronic infectious disease caused by Tropheryma whipplei. WD DNA has been found in stool and saliva specimens from patients and asymptomatic carriers.
. Diagnostic criteria for Tropheryma whipplei infection and asymptomatic carriage that were applied in our study. technologies and in knowledge about T. whipplei. Early techniques involved PCR assays targeting the 16S rRNA gene and the 16S-23S intergenic regions of T. whipplei [5, 12] . Later, a quantitative real-time PCR (qPCR) targeting this intergenic region was developed [13] . Most recently, a new qPCR that is based on genome analysis and that targets repeated sequences of T. whipplei has substantially enhanced sensitivity, compared with the previous qPCR assay, but has similar specificity [10] . For all of these assays, when an amplified product is detected, the identification of T. whipplei is confirmed by sequencing. More recently, specific oligonucleotide Taqman probes have been used for identification of T. whipplei [14] [15] [16] . Asymptomatic carriage, mainly in stool and saliva, has been reported; thus, it is a priori difficult to use these samples for diagnosis [3, 13, [16] [17] [18] [19] [20] [21] [22] [23] . However, we recently found that the bacterial load, as determined by qPCR, was higher in patients than in carriers [15] . Here, we report our 4-year experience with molecular diagnosis of WD by targeting repeated sequences to evaluate the role of molecular diagnosis of the disease.
PATIENTS, MATERIALS, AND METHODS
Patient recruitment. Our laboratory (Marseille, France) receives samples from many locations in France. For patients from Marseille, the samples are transported at room temperature. For patients outside Marseille, the samples are frozen at Ϫ80ЊC and transported on dry ice. When a result is consistent with WD, the physicians are asked to provide additional samples and data. This study is based on the analysis of samples tested from October 2003 through August 2007. The local ethics committee approved the study. Case definitions. The diagnostic criteria used for the case definitions are detailed in table 1. Our criteria for establishing a definite diagnosis of classic WD were the presence of positive results of periodic acid-Schiff staining and/or specific immunohistochemistry of a small-bowel biopsy specimen [3, 24] . The hallmark of localized extra-intestinal infection due to T. whipplei is the lack of histological lesions in the small-bowel biopsy specimens [3, 25] . On the basis of our results, patients were classified as having definite, excluded, or possible WD.
PCR assays. From October 2003 through March 2004, all specimens were tested by qPCR targeting repeated sequences of T. whipplei; when an amplified product was detected, sequencing was performed. Since April 2004, all specimens have been tested by qPCR targeting repeated sequences of T. whipplei with use of specific oligonucleotide Taqman probes for T. whipplei identification. A 10-fold dilution of a standard suspension of 10 6 T. whipplei strain Marseille-Twist was used as a positive control and for quantification, as reported elsewhere [15] . For each assay, at intervals of 5 samples, T. whipplei-negative water, PCR mix, and human samples were also evaluated. In cases of discrepancies between the 2 qPCR assays (mean number of instances per year, 8) or of incorrect controls (mean number of instances per year, 4), samples were submitted to additional DNA extraction and/or qPCR assays. A 1-g stool sample, a 200-mL saliva sample, 1 biopsy sample, or a 200-mL sample of body fluid was submitted for DNA extraction with the QIAamp DNA 
NOTE.
A true-positive result was defined as a positive saliva or stool specimen from a patient with Whipple disease (WD), and a false-positive result was defined as a positive saliva or stool specimen from a person without WD. A true-negative result was defined as a negative saliva or stool specimen from a person without WD, and a false-negative result was defined as positive saliva and stool specimens and a negative stool or saliva specimen from patients with WD. Sensitivity was defined as the number of true-positive results divided by the sum of true-positive and false-negative results. Specificity was defined as the number of true-negative results divided by the sum of true-negative and false-positive results. NA, not applicable; NPV, negative predictive value (defined as the number of true-negative results divided by the sum of true-negative and false-negative results); PPV, positive predictive value (defined as the number of true-positive results divided by the sum of true-positive and false-positive results). All PCR products were sequenced as described elsewhere [7] . If the result of this first assay was positive, the result was systematically confirmed by a second qPCR using a second set of primer pairs: 342 forward (5 -AGATGATGGATCTGCTTTCT-TATCTG-3 ) and 492 reverse (5 -AACCCTGTCCTGCACCCC-3 ). These pairs targeted a different DNA sequence with use of the same qPCR and sequencing protocol as described above.
Since April 2004, the T. whipplei-specific qPCR targeting a 155-base pair sequence of the bacterium incorporated the primer pair TW27 forward (5 -TGTTTTGTACTGCTTGTAAC-AGGATCT-3 ) and TW182 reverse (5 -TCCTGCTCTATCCCT-CCTATCATC-3 ), and a Taqman probe (27 forward-182 reverse, 6-FAM-AGAGATACATTTGTGTTAGTTGTTACA-TAMRA) was used in the reaction mix. qPCR was performed in a LightCycler, as described elsewhere [14] [15] [16] . If the result of this first assay was positive, the result was systematically confirmed by a second PCR using a second set of primer pairs: TW13 forward (5 -TGAGTGATGGTAGTCTGAGAGATATGT) and TW163 reverse (5 -TCCATAACAAAGACAACAACCAATC). This second PCR used a Taqman probe (13 forward-163 reverse, 6-FAM-AGAAGAAGATGTTACGGGTTG-TAMRA) that targeted a different 150-base pair sequence, as described elsewhere [14] [15] [16] .
Statistical methods. Sensitivity, specificity, negative predictive value, and positive predictive value (PPV) were calculated on the basis of the number of definite and excluded diagnoses. Statistical analysis was performed with use of EpiInfo, version 6.04a (Centers for Disease Control and Prevention). A statistically significant differential expression was considered when . P ! .05
RESULTS

Description of the population. From October 2003 through
August 2007, a total of 4418 samples from French patients were tested. A definite diagnosis of WD was determined for 71 pa- tients, and a definite diagnosis of classic WD was determined for 55 patients, 7 of whom had experienced relapse or therapeutic failure. A definite diagnosis of localized neurologic infection was made for 6 patients, and 4 patients were classified as having possible localized neurologic infection. A definite diagnosis of endocarditis was established for 5 patients. A definite diagnosis of uveitis was made for 2 patients, and 8 patients were considered to have possible uveitis. Definite diagnoses of localized adenopathy, pulmonary infection, and knee prosthesis infection were determined for 1 patient each. Seven patients were considered to be asymptomatic carriers (T. whipplei was found in their stool specimens) (tables 2-4). Saliva and stool specimens. Results for saliva and stool specimens are summarized in tables 2-4. Both saliva and stool specimens were available for 23 patients with classic WD; both samples were positive for 15 patients (65%), and both samples were negative for 1 patient (4.3%). Only stool specimens were positive for 7 patients. No patient presented with only a positive saliva specimen. For 6 patients with classic WD, only saliva specimens were available, and all were positive. For 1 patient with classic WD, only a stool specimen was available, and it was positive. For 4 of 12 patients with localized infection, qPCR results were positive for both saliva and stool specimens: 1 patient had neurologic infection, 1 had uveitis, 1 had blood culture-negative endocarditis (marked by positive results of PCR of a small-bowel biopsy specimen), and 1 had pulmonary infection. PCR results were negative for both saliva and stool specimens from 4 patients (1 had neurologic infection, and 3 had endocarditis). PCR results were positive for stool specimens and negative for saliva specimens from 3 patients (1 had neurologic infection, 1 had uveitis, and 1 had knee prosthesis infection). Finally, for 1 patient with adenopathy, PCR results were negative for saliva specimens, but PCR of a stool specimen was not performed. Seven (2.3%) of 299 patients were asymptomatic carriers with carriage in stool. All asymptomatic carriers had their saliva specimens tested, and only 1 specimen was positive. Thus, only 1 (0.2%) of 432 patients was considered to be an asymptomatic carrier with carriage in saliva. The mean bacterial load (‫ע‬SD) in stool specimens was 5 5.7 ϫ 10 ‫ע‬ cfu/g (range, 85 to cfu/g) for patients, com- 7.4 ϫ 10 ‫ע‬ 10 3 ϫ 10 asymptomatic carriers. Thus, the amounts of T. whipplei in stool samples from patients were significantly higher than those in stool samples from asymptomatic carriers ( ). A cutoff P p .02 T. whipplei load of 10 3 cfu/g of stool had a PPV of 96% but failed to provide a diagnosis for 4 patients (2 with classic WD and 2 with localized infection). A T. whipplei load of 10 4 cfu/ g of stool had a PPV of 100% but failed to provide a diagnosis for 6 additional patients with classic WD.
Digestive biopsy specimens. Twelve (23%) of the 52 patients who had definite infection had a small-bowel biopsy specimen negative for T. whipplei by qPCR, periodic acid-Schiff staining, and specific immunohistochemistry. All of these patients had no digestive symptoms, but 4 had localized neurologic infection, 3 had endocarditis, 2 had uveitis, 1 had adenitis, 1 had knee prosthesis infection, and 1 had pulmonary infection. One (0.26%) of the 380 patients who received a diagnosis of excluded WD was considered to be an asymptomatic carrier on the basis of testing of a duodenal biopsy specimen (table  4) . Three gastric biopsy specimens from patients with classic WD were tested in parallel with small-bowel biopsy specimens, and both types of specimens were positive for T. whipplei by qPCR. Only 1 of 3 colonic biopsy specimens from patients with classic WD was positive by qPCR. In addition, 1 patient was an asymptomatic carrier (T. whipplei was found in a colic biopsy specimen) (table 4) .
Other specimens. Seventeen (37%) of 46 blood specimens tested for patients with WD were qPCR positive. Blood specimens were negative for all patients who had specimens tested and who had localized neurologic infection, uveitis, adenopathy, or knee prosthesis infection. A positive blood qPCR result was determined for 1 of the 3 patients with endocarditis who had samples obtained. Positive CSF qPCR results were observed in several circumstances. Of the 17 patients with qPCR-positive CSF specimens, 6 presented with localized neurologic infection due to T. whipplei, 4 had classic WD without neurologic manifestations, 6 presented with classic WD with neurologic manifestations, and 1 had classic WD associated with uveitis. Of the 19 patients with negative specimens, 16 had classic WD without neurologic involvement, 2 had localized uveitis, and 1 had endocarditis. Four patients presented with possible localized neurologic infection due to T. whipplei. In our series, on the basis of testing of aqueous humor samples, 2 patients presented with definite localized uveitis due to T. whipplei. Eight patients were considered to have possible uveitis due to T.
whipplei. Four patients presented with positive results of qPCR of adenopathy samples (3 had classic WD with mesenteric adenopathies, and 1 had localized mediastinal adenopathy). One patient with localized pulmonary infection also had mediastinal adenopathy, but the specimen was qPCR negative. Three of 8 patients with classic WD had a positive urine qPCR result. For patients with localized infection, only 1 urine sample was tested, and it was qPCR negative. No asymptomatic carriage was found among 57 tested urine specimens.
DISCUSSION
To our knowledge, this is the first large case series to investigate the value of qPCR for the diagnosis of WD. The predictive value of PCR for WD is a major question because of the existence of false-positive and false-negative results and of asymptomatic carriers. Indeed, the main problem with PCR techniques is the risk of laboratory contamination. The risk is present during several steps of the PCR procedure, including during the obtainment of the samples, the isolation of the DNA, and the actual performance of the PCR assays [26, 27] . Seminested and nested PCR, which are associated with a high risk of contamination, should be avoided [28] . The validity of the data reported here is based on strict experimental procedures and controls, including rigorous positive and negative controls to validate the test. In addition, each positive PCR result was confirmed by the successful amplification of an additional DNA sequence. Thus, we believe that our results are valid, because they were cautiously checked, and we systematically tested the positive samples with use of an additional DNA target and performed an additional DNA extraction for each doubtful specimen.
There is also the problem of false-negative results attributable to the presence of inhibitors or low amounts of bacteria in the specimen. In this case, either all of the PCR assay results are negative, or only the result of the most sensitive PCR assay is positive. The latter situation may lead to a false-negative diagnosis. If the diagnosis of WD is ruled out, consequences may be dramatic, as suggested by the death of a patient for whom results of 1 of 3 PCR assays of joint fluid samples and duodenal biopsy samples were positive but for whom the result of periodic acid-Schiff staining of a duodenal biopsy sample was negative [29] . The positive PCR results were neglected, and a systemic clinical disorder of unknown origin was assumed, leading to treatment with indomethacin and prednisone. The patient died of multiorgan failure, but the autopsy revealed WD. Therefore, when only 1 of the 2 results of PCR of a CSF or aqueous humor specimen was confirmed to be positive, we preferred to consider the diagnosis of a localized infection linked to T. whipplei instead of excluding the diagnosis.
In our study, asymptomatic carriage of T. whipplei DNA in saliva and stool in the general population was less frequent than was reported elsewhere [3, 15, 18, 19] . In our study, only 2.3% of patients without WD were positive for T. whipplei. However, this carriage has been more frequently reported in sewer workers (12%-25%) and patients with hepatitis or cirrhosis than in the general population [15, 30] . Carriage in saliva also occurs less frequently (0.2%) in the general population than in sewer workers (2.2%) and has been observed only in those with carriage in stool [3, 15] . Presumptive diagnosis of WD should be highly considered when patients present with both saliva and stool specimens positive for T. whipplei by qPCR, which has a PPV of 95.2%. In addition, if the bacterial load in stool is 110 4 cfu/g, the PPV is 100%, and T. whipplei-specific PCR of blood, gastric, and small-bowel biopsy specimens should be performed. Conversely, classic WD is unlikely in patients with saliva or stool specimens negative for T. whipplei by qPCR, with a negative predictive value of 99.2%, and additional specific investigations for classic WD could be stopped. A diagnostic strategy for classic WD, depending on results of qPCR of saliva and stool specimens, is proposed in figure 1 . Finally, the fact that bacterial loads in stool specimens from carriers are low could explain the divergences of prevalence estimations between studies.
Classic WD is often suspected but is rarely diagnosed. A screening test by noninvasive qPCR of saliva and stool specimens may help to select the patients for whom testing of digestive biopsy specimens should be performed to confirm the diagnosis. The PPV for testing of duodenal biopsy specimens was 97.5% in our series. Asymptomatic carriage of T. whipplei DNA in small-bowel specimens was reported in 5% of patients in 1 study [19] , but these data have not been reproduced among other large series [13, 22] . In our series, the percentage of patients with asymptomatic carriage of T. whipplei in duodenal biopsy specimens was estimated to be 0.26%. Gastric biopsy specimens should be tested in parallel with small-bowel biopsy specimens. Testing of gastric biopsy specimens presents highly specific results. Even if our data show that such testing may lack sensitivity, it is important to underline that 1 recent report revealed that it may be helpful for the diagnosis when testing of small-bowel biopsy specimens failed [31] . Our data confirm that colonic biopsy specimens are not useful samples for the diagnosis of classic WD, because testing of such samples lacks both sensitivity and specificity.
Since October 2003, of the 71 WD diagnoses made, 16 (22.5%) corresponded to localized infection due to T. whipplei. The diagnosis of such cases without specific histological involvement is difficult and may be delayed. In this series, 1 of the 5 patients with T. whipplei endocarditis presented with a positive result of PCR of a duodenal biopsy specimen but negative results of periodic acid-Schiff staining and specific immunohistochemistry. It is uncertain whether these patients with localized infections will never have digestive involvement or The sample was obtained from a 67-year-old woman with myeloma who had positive quantitative real-time PCR results but negative results of periodic acid-Schiff staining and specific immunohistochemistry of a duodenal biopsy sample. A stool specimen obtained from the woman was also PCR positive, but her saliva specimen was negative.
h The sample was obtained from a 47-year-old man infected with HIV and hepatitis C virus who presented with chronic diarrhea. A stool specimen obtained from the man was positive for T. whipplei by quantitative real-time PCR, but his saliva, duodenal biopsy, and gastric biopsy specimens were negative. Histological analysis of his colonic biopsy specimen revealed chronic colitis, but results of periodic acid-Schiff staining and specific immunohistochemistry were negative. No other potential pathogens (parasites, viruses, or bacteria) were found.
whether they will develop it later. Indeed, it is possible that, at the beginning of WD onset, digestive involvement is sparse and focal, leading to diagnostic difficulties. Later, when the digestive form has developed, the diagnosis is more easily determined. Although qPCR of saliva and stool specimens is useful for diagnosis of classic WD, it is not efficient for diagnosis of localized infection, for which the samples tested will depend on the clinical manifestations. For localized endocarditis, a blood sample should be tested. One case of asymptomatic carriage in the blood was reported, but it was never confirmed [20] . In our study, the PPV of PCR of blood samples was 100%, and the main limitation of testing of blood samples is the lack of sensitivity [32] . Low amounts of T. whipplei DNA in blood and the presence of PCR inhibitors may explain this low sensitivity. Only 1 of 3 blood specimens from patients with localized endocarditis was positive for T. whipplei, underlining that it is still difficult to establish the diagnosis of this clinical entity. Currently, diagnosis is usually obtained with use of cardiac valve samples, removed during surgical procedures, that are tested mainly by broad-spectrum PCR targeting the 16S rRNA sequence, followed by sequencing.
Diagnosis of localized neurologic infection is still difficult. Clinical manifestations lack specificity and encompass a large spectrum of neurology [3, 33, 34] . PCR of a CSF specimen is highly specific, but it may lack sensitivity, as suggested by the discrepant results of qPCR of CSF specimens from 4 patients. When the result of CSF PCR is negative but a brain lesion is observed on MRI or CT, a brain biopsy can be performed to obtain a specimen for specific PCR analysis and immunohistochemistry. 16S rRNA PCR assay of CSF and brain biopsy specimens could also be useful, but this technique is less sensitive than qPCR [10] . Diagnosis of T. whipplei uveitis is difficult, because the amount of aqueous humor specimen is low, and testing of such specimens may lack sensitivity, as suggested by the discrepant results of our qPCR assays for 8 patients. In addition, after the first obtainment of samples, additional aqueous humor samples cannot be obtained for additional testing. Analysis of CSF samples did not help with the diagnosis of T. whipplei uveitis in our series. It is important to emphasize that 1 of the 2 diagnoses of definite T. whipplei uveitis was determined by molecular screening by 16S rRNA PCR. This diagnostic strategy by broad-spectrum PCR also allowed the diagnosis of localized pulmonary and knee prosthesis infection. Thus, in the context of a positive 16S rRNA PCR result, specific T. whipplei qPCR is useful to confirm the diagnosis.
When classic WD is suspected, qPCR screening of saliva and stool specimens should be performed first. When results of both tests are positive, diagnosis of WD is highly suspected, especially if bacterial load in stool is 110 4 cfu/g. When the results of the tests are negative, classic WD is unlikely. Localized disease, which accounts for nearly one-quarter of cases, can be suspected in a broad spectrum of clinical manifestations. In this case, qPCR of saliva and stool specimens lacks sensitivity. Broad-spectrum and specific qPCR assays, with use of specimens obtained on the basis of clinical manifestations, are necessary.
